Cargando...
Earlier the better: convalescent plasma
In the current issue of Blood, Xia et al evaluate the use of convalescent plasma for the treatment of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19).(1,2) SARS-CoV-2 has spurred a global crisis. To date, there are limited...
Gardado en:
| Publicado en: | Blood |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Hematology
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7414595/ https://ncbi.nlm.nih.gov/pubmed/32761223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020007638 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|